微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 54.64% | 4.9% | -0.95% | 65/159 | 50.44% | 迪哲医药 | 99.22% | 行业排名> |
| 2026-06-30 | 55.17% | 1.5% | -4.52% | 65/159 | 48.66% | 海创药业 | 97.34% | 行业排名> |
| 2026-03-31 | 57.78% | 3.06% | 13.07% | 61/159 | 50.28% | 海创药业 | 99.82% | 行业排名> |
| 2025-12-31 | 51.1% | -8.38% | -1.9% | 71/159 | 50.37% | 海创药业 | 98.62% | 行业排名> |
| 2025-09-30 | 52.09% | -9.37% | -4.17% | 69/159 | -2.13% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 54.35% | -10.06% | -3.05% | 66/159 | 15.05% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 56.06% | -10.74% | 0.52% | 61/159 | 31.79% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 55.77% | -10.15% | -2.96% | 66/159 | 51.61% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 57.47% | -8.42% | -4.9% | 61/159 | 22.43% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 60.43% | -1.8% | -3.79% | 51/159 | 32.96% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 62.81% | 2% | 1.19% | 44/159 | 51.47% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 62.07% | 2.56% | -1.08% | 47/159 | 51.31% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 62.75% | 2% | 1.97% | 46/159 | 32.31% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 61.54% | -9.4% | 1.68% | 54/159 | 38.22% | 迈威生物 | 99.8% | 行业排名> |
| 2022-12-31 | 60.52% | -7.89% | -7.89% | 56/159 | 53.51% | 迈威生物 | 99.46% | 行业排名> |
| 2021-12-31 | 65.71% | 2% | -3.26% | 51/159 | 54.9% | 迈威生物 | 99.75% | 行业排名> |
| 2021-06-30 | 67.93% | 2% | 2% | 42/159 | 46.97% | 迈威生物 | 99.67% | 行业排名> |